<Suppliers Price>

sodium glycocholate

Names

[ CAS No. ]:
863-57-0

[ Name ]:
sodium glycocholate

[Synonym ]:
Glycine, N-choloyl-, monosodium salt
EINECS 212-730-9
sodium {[(3α,5β,7α,8ξ,12α)-3,7,12-trihydroxy-24-oxocholan-24-yl]amino}acetate
GLYCOCHOLIC ACID SODIUM SALT
Glycine, N-((3α,5β,7α,12α)-3,7,12-trihydroxy-24-oxocholan-24-yl)-, monosodium salt (9CI)
MFCD00036741
Sodium {[(3α,5β,7α,12α)-3,7,12-trihydroxy-24-oxocholan-24-yl]amino}acetate
Glycine, N-[(3α,5β,7α,12α)-3,7,12-trihydroxy-24-oxocholan-24-yl]-, sodium salt (1:1)
Sodium glycocholate hydrate
glycine, N-[(3α,5β,7α,8ξ,12α)-3,7,12-trihydroxy-24-oxocholan-24-yl]-, sodium salt (1:1)

Biological Activity

[Description]:

Glycocholic acid sodium is an orally active bile acid with anticancer activity, targeting against pump resistance-related and non-pump resistance-related pathways[1].

[Related Catalog]:

Research Areas >> Others

[Target]

Microbial Metabolite

Human Endogenous Metabolite


[In Vitro]

Glycocholic acid (GC) increases the cytotoxicity of epirubicin, significantly increases the intracellular accumulation of epirubicin in Caco-2 cells and the absorption of epirubicin in rat small intestine, and intensified epirubicin-induced apoptosis. Glycocholic acid and epirubicin significantly reduce mRNA expression levels of human intestinal MDR1, MDR-associated protein (MRP)1, and MRP2; downregulate the MDR1 promoter region; suppress the mRNA expression of Bcl-2; induce the mRNA expression of Bax; and significantly increase the Bax-to-Bcl-2 ratio and the mRNA levels of p53, caspase-9 and -3. A combination of anticancer drugs with Glycocholic acid can control MDR via a mechanism that involves modulating P-gp and MRPs as well as regulating apoptosis-related pathways[1].

Chemical & Physical Properties

[ Boiling Point ]:
692ºC at 760 mmHg

[ Melting Point ]:
210-215 °C (subl.)(lit.)

[ Molecular Formula ]:
C26H42NNaO6

[ Molecular Weight ]:
487.604

[ Flash Point ]:
372.3ºC

[ Exact Mass ]:
487.290985

[ PSA ]:
129.92000

[ LogP ]:
1.62110

[ Index of Refraction ]:
30 ° (C=1, H2O)

[ Storage condition ]:
Refrigerator

MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
MB9265100
CHEMICAL NAME :
Glycine, N-choloyl-, monosodium salt
CAS REGISTRY NUMBER :
863-57-0
LAST UPDATED :
199404
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C26-H43-N-O6.Na
MOLECULAR WEIGHT :
488.69

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

MUTATION DATA

TEST SYSTEM :
Rodent - rat
DOSE/DURATION :
400 mg/kg
REFERENCE :
JJCREP Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- Volume(issue)/page/year: 78,32,1987 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 80519 No. of Facilities: 68 (estimated) No. of Industries: 1 No. of Occupations: 6 No. of Employees: 2770 (estimated)

Safety Information

[ Safety Phrases ]:
S22-S24/25

[ WGK Germany ]:
3

[ RTECS ]:
MB9265100

Synthetic Route

Precursor & DownStream


Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.